Spine Biologics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Spine Biologics Market is segmented By Product (Bone Graft Substitutes, Spinal Allografts, Others), By End User and Geography.

Home Market Analysis Healthcare Research Pharmaceuticals Research Finished Dosage Form Research Biologics Research Spine Biologics Industry

Spine Biologics Market Size

Spine Biologics Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 4.00 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Spine Biologics Market Major Players

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Spine Biologics Market Analysis

The Spine Biologics Market is expected to register a CAGR of 4% during the forecast period. This is attributing to the growing geriatric population, rising prevalence of spine deformities, and technological advancements in bone grafting procedures. In addition, rising incidences of degenerative spine disorders with a significant increase in treatment rates and increasing preference for minimally invasive procedures are also fueling the growth of the market. Moreover, interbody fusion and direct lateral interbody fusion are the two advanced biological mechanisms for the treatment of the deformity of the spine and are highly adopted among surgeons globally. Furthermore, Advancements in the biomaterial and minimally invasive procedure approach associated with lateral body fusion is an ideal approach for the treatment of spine disorders as this procedure results in safe, effective, fast recovery and less injury. It further promotes the demand for spine biologics in the treatment of disc generation, sclerosis and other spine-related disorders. Spine injuries are very common among the population who are above 50 years as they are more susceptible to have structural alteration in the spine or spinal impairments thus growing geriatric population around worldwide will also promote the demand of treatment and diagnosis of the disorders. Therefore, the aforementioned factors will drive the spine biologics market in forecasted period.

Spine Biologics Market Trends

This section covers the major market trends shaping the Spine Biologics Market according to our research experts:

Spinal Allografts in Spinal Biologics is Estimated to Witness a Healthy Growth in Future

Spinal allografts are estimated to witness healthy growth in the future which is attributed to several benefits associated with its usage. Spinal allografts are the allograft bone that is donated from another patient (donor) and used in the spine treatment procedure. The use of allografts in spinal fusion will eliminate the additional surgical procedure that is reduced surgery time. In addition, these are osteoconductive which means it provides a scaffold to the spine repair. Moreover, several companies are working and providing on natural bone grafts that are harvested from the donor body. For instance, Zimmer Biomet offers RegenerOss Resorbable Xenograft (natural bone grafts). Products from such international and well-established companies indicate the demand for spinal allografts in the market.

Spine Biologics Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Spine Biologics Market due to the presence of the geriatric population, increasing adoption of minimally invasive procedure, and rising prevalence of spine disorders such as spondylolisthesis, spinal stenosis, and disc-related issue. As per the American Association of Neurological Surgeons, every year an estimate of 17,000 new cases of spinal cord injury reported in the United States. Thus a large number of spinal cord injury population will significantly promote the demand for the treatment of disorders wherein spinal biologics plays an important role in diagnosis and thereby driving the overall market The United States owns the largest share of Spine Biologics Market in the North America region Furthermore, well-established infrastructure, stable economic growth, growing health care expenditure is also expected to fuel the Spine Biologics Market in this region.

Spine Biologics Market Growth

Spine Biologics Industry Overview

The Spine Biologics Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Johnson & Johnson (Depuy Synthes), Orthofix Medical Inc., Stryker Corporation, Zimmer Biomet, Arthrex, Inc., Exactech, Inc, Medtronic plc, etc.

Spine Biologics Market Leaders

  1. Orthofix Medical Inc

  2. Zimmer Biomet

  3. Arthrex, Inc.

  4. Johnson & Johnson (Depuy Synthes)

  5. Stryker Corporation

*Disclaimer: Major Players sorted in no particular order

Johnson & Johnson (Depuy Synthes), Orthofix Medical Inc., Stryker Corporation, Zimmer Biomet, Arthrex, Inc., Exactech, Inc, Medtronic plc
Need More Details on Market Players and Competitors?
Download Sample

Spine Biologics Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Geriatric Population

      2. 4.2.2 Growing Prevalence of Spine Deformities

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Reimbursement Policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Bone Graft Substitutes

        1. 5.1.1.1 Bone Morphogenetic Proteins

        2. 5.1.1.2 Synthetic Bone Grafts

      2. 5.1.2 Spinal Allografts

        1. 5.1.2.1 Machined Bones Allograft

        2. 5.1.2.2 Demineralized Bone Matrix

      3. 5.1.3 Others

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Surgical Centers

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Johnson And Johnson (Depuy Synthes)

      2. 6.1.2 Orthofix Medical Inc.

      3. 6.1.3 Stryker Corporation

      4. 6.1.4 Zimmer Biomet

      5. 6.1.5 Arthrex, Inc.

      6. 6.1.6 Exactech, Inc

      7. 6.1.7 Spine Wave, Inc.

      8. 6.1.8 Medtronic plc

      9. 6.1.9 NuVasive, Inc.

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape includes Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Spine Biologics Industry Segmentation

As per the scope, Spine biologics comprises biomaterials that are used in the treatment of spinal cord injuries, degenerative disc diseases, and bone fusion surgeries. It mainly stimulates the growth of bone formation by different stages which involve inflammatory, repair, and remodeling. Spine Biologics Market is segmented By Product, End-User, and Geography.

By Product
Bone Graft Substitutes
Bone Morphogenetic Proteins
Synthetic Bone Grafts
Spinal Allografts
Machined Bones Allograft
Demineralized Bone Matrix
Others
By End User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Spine Biologics Market Research FAQs

The Spine Biologics Market is projected to register a CAGR of 4% during the forecast period (2024-2029)

Orthofix Medical Inc, Zimmer Biomet, Arthrex, Inc., Johnson & Johnson (Depuy Synthes) and Stryker Corporation are the major companies operating in the Spine Biologics Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Spine Biologics Market.

The report covers the Spine Biologics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Spine Biologics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Spine Biologics Industry Report

Statistics for the 2024 Spine Biologics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Spine Biologics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Spine Biologics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Spine Biologics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)